Aspirin versus clopidogrel as single antithrombotic therapy after transcatheter aortic valve replacement: insight from the OCEAN-TAVI registry

Y Kobari, T Inohara, T Saito, N Yoshijima… - Circulation …, 2021 - Am Heart Assoc
Background: Current guidelines recommend dual antiplatelet therapy for the first 1 to 6
months after transcatheter aortic valve replacement (TAVR); however, recent studies have …

Aspirin Versus Clopidogrel as Single Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry

Y Kobari, T Inohara, T Saito… - Circulation …, 2021 - keio.elsevierpure.com
Background: Current guidelines recommend dual antiplatelet therapy for the first 1 to 6
months after transcatheter aortic valve replacement (TAVR); however, recent studies have …

Aspirin Versus Clopidogrel as Single Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry

Y Kobari, T Inohara, T Saito… - Circulation …, 2021 - u-toyama.elsevierpure.com
Background: Current guidelines recommend dual antiplatelet therapy for the first 1 to 6
months after transcatheter aortic valve replacement (TAVR); however, recent studies have …

Aspirin Versus Clopidogrel as Single Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.

Y Kobari, T Inohara, T Saito, N Yoshijima… - Circulation …, 2021 - europepmc.org
Background Current guidelines recommend dual antiplatelet therapy for the first 1 to 6
months after transcatheter aortic valve replacement (TAVR); however, recent studies have …

Aspirin Versus Clopidogrel as Single Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry

Y Kobari, T Inohara, T Saito… - Circulation …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Current guidelines recommend dual antiplatelet therapy for the first 1 to 6
months after transcatheter aortic valve replacement (TAVR); however, recent studies have …

Aspirin Versus Clopidogrel as Single Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry

Y Kobari, T Inohara, T Saito… - Circulation …, 2021 - keio.elsevierpure.com
Background: Current guidelines recommend dual antiplatelet therapy for the first 1 to 6
months after transcatheter aortic valve replacement (TAVR); however, recent studies have …